207 related articles for article (PubMed ID: 27387676)
21. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
[TBL] [Abstract][Full Text] [Related]
22. Rhabdomyosarcoma of the bladder and prostate in children.
Kamat MR; Kulkarni JN; Tongaonkar HB; Ravi R
J Surg Oncol; 1991 Nov; 48(3):180-2. PubMed ID: 1943114
[TBL] [Abstract][Full Text] [Related]
23. [Prostate-bladder rhabdomyosarcoma: therapeutic approaches].
Vesga Molina F; Albisu Tristan A; Blasco de Villalonga M; Llarena Ibarguren R; Pertusa Peña C
Arch Esp Urol; 1994 Dec; 47(10):985-9. PubMed ID: 7864680
[TBL] [Abstract][Full Text] [Related]
24. Organ-preserving management of rhabdomyosarcoma of the prostate and bladder in children.
Silván AM; Gordillo MJ; Lopez AM; Cuevas GP; Gutiérrez JA; Iriondo JM; Cantón JA; Caro AM; Quesada ML; Arceaga MA; Vallés MC
Med Pediatr Oncol; 1997 Dec; 29(6):573-5. PubMed ID: 9324347
[TBL] [Abstract][Full Text] [Related]
25. Current standards of care in bladder and prostate rhabdomyosarcoma.
Kieran K; Shnorhavorian M
Urol Oncol; 2016 Feb; 34(2):93-102. PubMed ID: 26776454
[TBL] [Abstract][Full Text] [Related]
26. Outcome, Treatment, and Treatment Failures in Patients Suffering Localized Embryonal Paratesticular Rhabdomyosarcoma: Results From the "Cooperative Weichteilsarkom Studiengruppe" Trials CWS-86, -91, -96, and -2002P.
Seitz G; Fuchs J; Martus P; Klingebiel T; Leuschner I; Schuck A; Dantonello TM; Koscielniak E;
Ann Surg; 2016 Dec; 264(6):1148-1155. PubMed ID: 27828824
[TBL] [Abstract][Full Text] [Related]
27. Current Treatment of Pediatric Bladder and Prostate Rhabdomyosarcoma.
Saltzman AF; Cost NG
Curr Urol Rep; 2018 Feb; 19(1):11. PubMed ID: 29468476
[TBL] [Abstract][Full Text] [Related]
28. Children with vesical rhabdomyosarcoma (RMS) treated by partial cystectomy with neoadjuvant or adjuvant chemotherapy, with or without radiotherapy. A report from the Intergroup Rhabdomyosarcoma Study (IRS) Committee.
Hays DM; Raney RB; Wharam MD; Wiener E; Lobe TE; Andrassy RJ; Lawrence W; Johnston J; Webber B; Maurer HM
J Pediatr Hematol Oncol; 1995 Feb; 17(1):46-52. PubMed ID: 7743237
[TBL] [Abstract][Full Text] [Related]
29. Bladder/prostate rhabdomyosarcoma: results of the multi-institutional trials of the Intergroup Rhabdomyosarcoma Study.
Hays DM
Semin Surg Oncol; 1993; 9(6):520-3. PubMed ID: 8284571
[TBL] [Abstract][Full Text] [Related]
30. Image of the month--quiz case. Bladder Rhabdomyosarcoma.
Joseph A; Vaughan RA
Arch Surg; 2010 Dec; 145(12):1211, 1212. PubMed ID: 21173297
[No Abstract] [Full Text] [Related]
31. Conservative approach in localised rhabdomyosarcoma of the bladder and prostate: results from International Society of Paediatric Oncology (SIOP) studies: malignant mesenchymal tumour (MMT) 84, 89 and 95.
Jenney M; Oberlin O; Audry G; Stevens MC; Rey A; Merks JH; Kelsey A; Gallego S; Haie-Meder C; Martelli H
Pediatr Blood Cancer; 2014 Feb; 61(2):217-22. PubMed ID: 23997024
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of systemic chemotherapy and intra-arterial chemotherapy with/without radiotherapy for bladder preservation or as neo-adjuvant therapy in patients with muscle-invasive bladder cancer: a single-centre study of 163 patients.
Miyata Y; Nomata K; Ohba K; Matsuo T; Hayashi N; Sakamoto I; Uetani M; Sakai H
Eur J Surg Oncol; 2015 Mar; 41(3):361-7. PubMed ID: 25312685
[TBL] [Abstract][Full Text] [Related]
33. Primary chemotherapy in the treatment of children with bladder--prostate tumors in the Intergroup Rhabdomyosarcoma Study (IRS-II).
Hays DM; Raney RB; Lawrence W; Tefft M; Soule EH; Crist WM; Foulkes M; Maurer HM
J Pediatr Surg; 1982 Dec; 17(6):812-20. PubMed ID: 6761418
[TBL] [Abstract][Full Text] [Related]
34. Prognostic factors in bladder and bladder-prostate rhabdomyosarcoma.
La Quaglia MP; Ghavimi F; Herr H; Mandell L; Pennenberg D; Hajdu S; Exelby PR
J Pediatr Surg; 1990 Oct; 25(10):1066-72. PubMed ID: 2262860
[TBL] [Abstract][Full Text] [Related]
35. Conservative treatment of invasive bladder carcinoma by transurethral resection, protracted intravenous infusion chemotherapy, and hyperfractionated radiotherapy: long term results.
Danesi DT; Arcangeli G; Cruciani E; Altavista P; Mecozzi A; Saracino B; Orefici F
Cancer; 2004 Dec; 101(11):2540-8. PubMed ID: 15481058
[TBL] [Abstract][Full Text] [Related]
36. [Conservative treatment of locally advanced bladder carcinoma: neoadjuvant chemotherapy, TUR and radiotherapy. Results in 40 patients].
Serretta V; Vasile P; Falletta V; Piazza F; Pavone C; Pavone-Macaluso M
Arch Ital Urol Androl; 1998 Jun; 70(3 Suppl):37-40. PubMed ID: 9707769
[TBL] [Abstract][Full Text] [Related]
37. Rhabdomyosarcoma of bladder and prostate.
de Kraker J; Russel IM; Voûte PA
Pediatr Hematol Oncol; 1988; 5(3):253-5. PubMed ID: 3152970
[No Abstract] [Full Text] [Related]
38. [The role of brachytherapy in the therapeutic strategy of vesico-prostatic rhabdomyosarcoma in children].
Haie-Meder C; Flamant F; Revillon Y; Valayer J; Gruner M; Martelli H; Habrand JL; Terrier-Lacombe MJ; Gerbaulet A
Ann Urol (Paris); 1994; 28(6-7):302-5. PubMed ID: 7893115
[TBL] [Abstract][Full Text] [Related]
39. Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802.
Tester W; Caplan R; Heaney J; Venner P; Whittington R; Byhardt R; True L; Shipley W
J Clin Oncol; 1996 Jan; 14(1):119-26. PubMed ID: 8558186
[TBL] [Abstract][Full Text] [Related]
40. Current treatment of pediatric bladder and prostate rhabdomyosarcoma (bladder preserving vs. radical cystectomy).
Castagnetti M; Herbst KW; Esposito C
Curr Opin Urol; 2019 Sep; 29(5):487-492. PubMed ID: 31188163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
